https://www.prweb.com/releases/abreos-biosciences-launches-laboratory-developed-test-for-precision-dose-monitoring-of-natalizumab-tysabri--840497137.html
Abreos Biosciences Launches Laboratory Developed Test for Precision Dose Monitoring of Natalizumab...
/PRNewswire-PRWeb/ -- Abreos Biosciences, a San Diego-based biotech company and leader in the precision dosing of biological therapeutics, is pleased to...
laboratory developed test